He said that in India, we extensively used our traditional medicines to supplement our fight against Covid-19 and to boost immunity, saving countless lives
This increase has been a result of the robust sales of immunity boosters. TheLifekart.in witnessed 25% increase from North India and is expecting 20% in the upcoming months.
This investment will enable Eyestem to reach their goal of becoming one of the first few companies in the world to develop a treatment for Dry Age-related Macular Degeneration (Dry AMD), the leading cause of incurable blindness affecting almost 170 million people – mostly above 50 years of age – across the globe.
As per the deal, Pharmeasy will absorb Medlife's existing customers. To set up their accounts, Medlife's customers will have to log in on PharmEasy's mobile application using the same mobile number they were using Medlife.